Demand for biologics and biosimilar drugs, a big push for cell-based assays market

The biotech revolution has ushered a new class of therapeutic agent known as biologics, they treat common to life-threatening diseases such as arthritis, cancer, diabetes, and inflammatory diseases. Because biologics are highly target specific, and efficient in treating disease conditions there has been an increasing interest from large pharma companies to niche players, to have… Continue reading Demand for biologics and biosimilar drugs, a big push for cell-based assays market

The battle to control Continuous Glucose Monitoring (CGM) market

Diabetes, a chronic condition, was once considered a disease of affluent countries, but within a short span of time, it has rapidly emerged as one of the leading cause of death in low and middle-income countries. Cause for the diabetes pandemic has been attributed to rapid urbanization, unhealthy diets, increasingly sedentary lifestyles and higher rates… Continue reading The battle to control Continuous Glucose Monitoring (CGM) market